New biomarkers of liver injury are required in the clinic and in preclinical pharmaceutical evaluation. Previous studies demonstrate that two liver-enriched microRNAs (miR-122 and miR-192) are promising biomarkers of acetaminophen-induced acute liver injury (APAP-ALI) in mice. We have examined these
The potential of cytokines as safety biomarkers for drug-induced liver injury
โ Scribed by Hugh G. Laverty; Daniel J. Antoine; Craig Benson; Masautso Chaponda; Dominic Williams; B. Kevin Park
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 720 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The Roussel Uclaf Causality Assessment Method (RUCAM) was developed to quantify the strength of association between a liver injury and the medication implicated as causing the injury. However, its reliability in a research setting has never been fully explored. The aim of this study was to determine
Increased age and female sex are suggested risk factors for drug-induced hepatotoxicity (DILI). We studied the influence of these variables on the propensity to develop DILI, as well as its clinical expression and outcome. All cases of DILI submitted to the Spanish Registry between April 1994 and Au
## Abstract The pathogenesis of immuneโmediated drugโinduced liver injury (DILI) following halogenated anesthetics, carbamazepine or alcohol has not been fully elucidated. Detecting cytochrome P450 2E1 (CYP2E1) IgG4 autoโantibodies in anesthetic DILI patients suggests a role for ILโ4 in this hapten